Very promising biosimilarity in biogenerics? <img src=http://www.xs4all.nl/~surg3on/INSM/INSM.2007.nov.6th.Rodham.presentation/11.jpg> <img src=http://www.xs4all.nl/~surg3on/INSM/INSM.2007.nov.6th.Rodham.presentation/13.jpg> <img src=http://www.xs4all.nl/~surg3on/INSM/INSM.2007.nov.6th.Rodham.presentation/14.jpg> <img src=http://www.xs4all.nl/~surg3on/INSM/INSM.2007.nov.6th.Rodham.presentation/15.jpg> <img src=http://www.xs4all.nl/~surg3on/INSM/INSM.2007.nov.6th.Rodham.presentation/16.jpg> <img src=http://www.xs4all.nl/~surg3on/INSM/INSM.2007.nov.6th.Rodham.presentation/17.jpg> <img src=http://www.xs4all.nl/~surg3on/INSM/INSM.2007.nov.6th.Rodham.presentation/18.jpg> development cost indication: 20-30million US dollar for a billion dollar market opportunity Full nov 6th presentation: <a href="http://www.xs4all.nl/~surg3on/INSM/INSM.2007.nov.6th.Rodham.presentation/" target="_blank">http://www.xs4all.nl/~surg3on/INSM/INSM.2007.nov.6th.Rodham.presentation/</a>